These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

286 related items for PubMed ID: 27471987

  • 21. Five-year follow-up of polymer-free sirolimus- and probucol-eluting stents versus new generation zotarolimus-eluting stents in patients presenting with st-elevation myocardial infarction.
    Colleran R, Kufner S, Harada Y, Giacoppo D, Cassese S, Repp J, Wiebe J, Lohaus R, Lahmann A, Schneider S, Ibrahim T, Laugwitz KL, Kastrati A, Byrne RA, Intracoronary Stenting and Angiographic Results: Test Efficacy of Sirolimus- and Probucol-Eluting Versus Zotarolimus-Eluting Stents (ISAR-TEST 5) Investigators.
    Catheter Cardiovasc Interv; 2017 Feb 15; 89(3):367-374. PubMed ID: 27377301
    [Abstract] [Full Text] [Related]

  • 22. Early outcome of magnesium bioresorbable scaffold implantation in acute coronary syndrome-the initial report from the Magmaris-ACS registry.
    Wlodarczak A, Lanocha M, Jastrzebski A, Pecherzewski M, Szudrowicz M, Jastrzebski W, Nawrot J, Lesiak M.
    Catheter Cardiovasc Interv; 2019 Apr 01; 93(5):E287-E292. PubMed ID: 30537203
    [Abstract] [Full Text] [Related]

  • 23. Impact of renin-angiotensin system inhibitors on long-term clinical outcomes in patients with acute myocardial infarction treated with successful percutaneous coronary intervention with drug-eluting stents: Comparison between STEMI and NSTEMI.
    Kim YH, Her AY, Jeong MH, Kim BK, Lee SY, Hong SJ, Shin DH, Kim JS, Ko YG, Choi D, Hong MK, Jang Y.
    Atherosclerosis; 2019 Jan 01; 280():166-173. PubMed ID: 30529829
    [Abstract] [Full Text] [Related]

  • 24. New generation drug-eluting stents for ST-elevation myocardial infarction: a new paradigm for safety.
    Garg A, Brodie BR, Stuckey TD, Garberich RF, Tobbia P, Hansen C, Kissling G, Kadakia H, Lips D, Henry TD.
    Catheter Cardiovasc Interv; 2014 Nov 15; 84(6):955-62. PubMed ID: 24174334
    [Abstract] [Full Text] [Related]

  • 25. Comparison Between Beta-Blockers with Angiotensin-Converting Enzyme Inhibitors and Beta-Blockers with Angiotensin II Type I Receptor Blockers in ST-Segment Elevation Myocardial Infarction After Successful Percutaneous Coronary Intervention with Drug-Eluting Stents.
    Kim YH, Her AY, Jeong MH, Kim BK, Lee SY, Hong SJ, Shin DH, Kim JS, Ko YG, Choi D, Hong MK, Jang Y.
    Cardiovasc Drugs Ther; 2019 Feb 15; 33(1):55-67. PubMed ID: 30632033
    [Abstract] [Full Text] [Related]

  • 26. Relationship Between Femoral Vascular Closure Devices and Short-Term Mortality From 271 845 Percutaneous Coronary Intervention Procedures Performed in the United Kingdom Between 2006 and 2011: A Propensity Score-Corrected Analysis From the British Cardiovascular Intervention Society.
    Farooq V, Goedhart D, Ludman P, de Belder MA, Harcombe A, El-Omar M, British Cardiovascular Intervention Society and the National Institute for Cardiovascular Outcomes Research.
    Circ Cardiovasc Interv; 2016 Jun 15; 9(6):. PubMed ID: 27225421
    [Abstract] [Full Text] [Related]

  • 27. An Upfront Two-Stent Strategy for True Coronary Bifurcation Lesions with A Large Side Branch in Acute Coronary Syndrome: A Two-Year Follow-Up Study.
    Yurtdaş M, Asoğlu R, Özdemir M, Asoğlu E.
    Medicina (Kaunas); 2020 Feb 29; 56(3):. PubMed ID: 32121323
    [Abstract] [Full Text] [Related]

  • 28. Impact of an optical coherence tomography guided approach in acute coronary syndromes: A propensity matched analysis from the international FORMIDABLE-CARDIOGROUP IV and USZ registry.
    Iannaccone M, D'Ascenzo F, Frangieh AH, Niccoli G, Ugo F, Boccuzzi G, Bertaina M, Mancone M, Montefusco A, Amabile N, Sardella G, Motreff P, Toutouzas K, Colombo F, Garbo R, Biondi-Zoccai G, Tamburino C, Omedè P, Moretti C, D'amico M, Souteyrand G, Meieir P, Lüscher TF, Gaita F, Templin C.
    Catheter Cardiovasc Interv; 2017 Aug 01; 90(2):E46-E52. PubMed ID: 28029210
    [Abstract] [Full Text] [Related]

  • 29. Sex Differences Persist in Time to Presentation, Revascularization, and Mortality in Myocardial Infarction Treated With Percutaneous Coronary Intervention.
    Stehli J, Martin C, Brennan A, Dinh DT, Lefkovits J, Zaman S.
    J Am Heart Assoc; 2019 May 21; 8(10):e012161. PubMed ID: 31092091
    [Abstract] [Full Text] [Related]

  • 30. A randomized comparison of novel bioresorbable polymer sirolimus-eluting stent and durable polymer everolimus-eluting stent in patients with acute coronary syndromes: The CENTURY II high risk ACS substudy.
    Jiménez VA, Iñiguez A, Baz JA, Valdés M, Ortiz A, Vuilliomenet A, Mainar V, Dudek D, Banai S, Tüller D, Bonnet JL, De Miguel A, Bastos G, Wijns W, Saito S.
    Cardiovasc Revasc Med; 2016 Sep 21; 17(6):355-61. PubMed ID: 27156201
    [Abstract] [Full Text] [Related]

  • 31. Procedural and Long-Term Outcomes of Bioresorbable Scaffolds Versus Drug-Eluting Stents in Chronic Total Occlusions: The BONITO Registry (Bioresorbable Scaffolds Versus Drug-Eluting Stents in Chronic Total Occlusions).
    Azzalini L, Giustino G, Ojeda S, Serra A, La Manna A, Ly HQ, Bellini B, Benincasa S, Chavarría J, Gheorghe LL, Longo G, Miccichè E, D'Agosta G, Picard F, Pan M, Tamburino C, Latib A, Carlino M, Chieffo A, Colombo A.
    Circ Cardiovasc Interv; 2016 Oct 21; 9(10):. PubMed ID: 27765802
    [Abstract] [Full Text] [Related]

  • 32. Gender differences in long-term outcome after primary percutaneous intervention for ST-segment elevation myocardial infarction.
    Wijnbergen I, Tijssen J, van 't Veer M, Michels R, Pijls NH.
    Catheter Cardiovasc Interv; 2013 Sep 01; 82(3):379-84. PubMed ID: 23553888
    [Abstract] [Full Text] [Related]

  • 33. Current characteristics and management of ST elevation and non-ST elevation myocardial infarction in the Tokyo metropolitan area: from the Tokyo CCU network registered cohort.
    Miyachi H, Takagi A, Miyauchi K, Yamasaki M, Tanaka H, Yoshikawa M, Saji M, Suzuki M, Yamamoto T, Shimizu W, Nagao K, Takayama M.
    Heart Vessels; 2016 Nov 01; 31(11):1740-1751. PubMed ID: 26758733
    [Abstract] [Full Text] [Related]

  • 34. Three-year efficacy and safety of new- versus early-generation drug-eluting stents for unprotected left main coronary artery disease insights from the ISAR-LEFT MAIN and ISAR-LEFT MAIN 2 trials.
    Cassese S, Kufner S, Xhepa E, Byrne RA, Kreutzer J, Ibrahim T, Tiroch K, Valgimigli M, Tölg R, Fusaro M, Schunkert H, Laugwitz KL, Mehilli J, Kastrati A.
    Clin Res Cardiol; 2016 Jul 01; 105(7):575-84. PubMed ID: 26689707
    [Abstract] [Full Text] [Related]

  • 35. Comparison of drug-eluting and bare-metal stents for primary percutaneous coronary intervention with or without abciximab in ST-segment elevation myocardial infarction: DEBATER: the Eindhoven reperfusion study.
    Wijnbergen I, Helmes H, Tijssen J, Brueren G, Peels K, van Dantzig JM, Van' t Veer M, Koolen JJ, Pijls NH, Michels R.
    JACC Cardiovasc Interv; 2012 Mar 01; 5(3):313-22. PubMed ID: 22440498
    [Abstract] [Full Text] [Related]

  • 36. Immediate and 1-year follow-up with the novel nanosurface modified COBRA PzF stent.
    Maillard L, Tavildari A, Barra N, Billé J, Joly P, Peycher P, Silvestri M, Vochelet F.
    Arch Cardiovasc Dis; 2017 Dec 01; 110(12):682-688. PubMed ID: 29102364
    [Abstract] [Full Text] [Related]

  • 37. Effect of postprocedural full-dose infusion of bivalirudin on acute stent thrombosis in patients with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention: Outcomes in a large real-world population.
    Wang H, Liang Z, Li Y, Li B, Liu J, Hong X, Lu X, Wu J, Zhao W, Liu Q, An J, Li L, Pu F, Ming Q, Han Y.
    Cardiovasc Ther; 2017 Jun 01; 35(3):. PubMed ID: 28083915
    [Abstract] [Full Text] [Related]

  • 38. Borderline trend towards long-term mortality benefit from drug eluting stents implantation in ST-elevation myocardial infarction patients in Poland-data from NRDES registry.
    Siudak Z, Dziewierz A, Rakowski T, Żmudka K, Legutko J, Bartuś S, Dragan J, Zasada W, Tokarek T, Kułaga T, Partyka Ł, Dudek D.
    Catheter Cardiovasc Interv; 2014 Feb 15; 83(3):436-42. PubMed ID: 24038740
    [Abstract] [Full Text] [Related]

  • 39. Comparative long-term efficacy and safety of drug-eluting stent versus coronary artery bypass grafting in ostial left main coronary artery disease: analysis of the MAIN-COMPARE registry.
    Lee SW, Kim SH, Kim SO, Han S, Kim YH, Park DW, Kang SJ, Lee CW, Park SW, Park SJ.
    Catheter Cardiovasc Interv; 2012 Aug 01; 80(2):206-12. PubMed ID: 22234884
    [Abstract] [Full Text] [Related]

  • 40. Mortality after percutaneous coronary revascularization: Prior cardiovascular risk factor control and improved outcomes in patients with diabetes mellitus.
    Noman A, Balasubramaniam K, Alhous MHA, Lee K, Jesudason P, Rashid M, Mamas MA, Zaman AG.
    Catheter Cardiovasc Interv; 2017 Jun 01; 89(7):1195-1204. PubMed ID: 28029209
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 15.